NEW YORK and BOSTON--(BUSINESS WIRE)--Accenture (NYSE: ACN) has invested, through Accenture Ventures, in 1910 Genetics (or “1910”), a biotechnology company advancing small and large molecule drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback